White Paper
Parkview Health
To improve patient outcomes and increase health equity, Parkview Health has brought Digital Diagnostics’ FDA cleared artificial intelligence system, LumineticsCore™ (formerly IDx-DR), to the point-of-care to improve comprehensive diabetes management through the autonomous detection of diabetic retinopathy (including macular edema).
Read this white paper to find out more about Parkview Health and LumineticsCore
- 3 lab and endo facilities providing LumineticsCore exams at the point-of-care
- 326 patients tested for diabetic retinopathy eye disease using LumineticsCore in 2021
- 46% of patients tested positive for diabetic eye disease
View the Parkview Health White Paper
Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.